Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.20.4
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interest
Total
Balance at Sep. 30, 2019 $ 28,930 $ 80,169,724 $ (53,045,782) $ 27,152,872
Balance, shares at Sep. 30, 2019   28,930,493        
Issuance of common stock upon exercise of warrants $ 1,061 (955) 106
Issuance of common stock upon exercise of warrants, shares   1,060,615        
Issuance of common stock for services $ 187 99,813 100,000
Issuance of common stock for services, shares   186,566        
Stock-based compensation expense 220,384 220,384
Net loss (4,322,370) (4,322,370)
Balance at Dec. 31, 2019 $ 30,178 80,488,966 (57,368,152) 23,150,992
Balance, shares at Dec. 31, 2019   30,177,674        
Balance at Sep. 30, 2020 $ 55,577 104,208,958 (70,593,867) 33,670,668
Balance, shares at Sep. 30, 2020   55,576,996        
Issuance of NoveCite common stock 1,799,640 (2,399,520) 600,380 500
Stock-based compensation expense 276,582 276,582
Net loss (8,146,909) (8,146,909)
Balance at Dec. 31, 2020 $ 55,577 $ 106,285,180 $ (81,140,296) $ 600,380 $ 25,800,841
Balance, shares at Dec. 31, 2020   55,576,996